Faculty 2016-07-08T07:55:56+00:00


Roberta Eileen Brinton, PhD


Pharmacology and Pharmaceutical Sciences
PSC 502
Health Sciences Campus
Los Angeles

+1 323 442 1430


Professor Brinton earned her Ph.D. in Psychobiology and Neuropharmacology from the University of Arizona as a National Institutes of Health Predoctoral fellow. She continued her postdoctoral research in Neuroendocrinology at Rockefeller University as a National Institutes of Health postdoctoral fellow and joined the USC faculty in 1988.

Dr. Roberta Diaz Brinton is the R. Pete Vanderveen Endowed Chair in Therapeutic Discovery and Development and Professor of Pharmacology and Pharmaceutical Sciences, School of Pharmacy and Biomedical Engineering at the University of Southern California. She is the Director of the USC Science, Technology and Research Program (STAR) science education outreach program. Dr. Brinton is also the Director of the Center for Scientific Translation within the Los Angeles Basin Clinical Translational Science Institute whose partner institutions include the University of Southern California, Childrens Hospital Los Angeles, Kaiser Permanente of Southern California and City of Hope.


Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat Rev Endocrinol. 2013 Apr; 9(4):241-50. View in: PubMed

Minireview: translational animal models of human menopause: challenges and emerging opportunities. Endocrinology. 2012 Aug; 153(8):3571-8. View in: PubMed

Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol Sci. 2009 Apr; 30(4):212-22. View in: PubMed

The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 2008 Oct; 31(10):529-37. View in: PubMed

Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev. 2008 Oct-Nov; 60(13-14):1504-11. View in: PubMed

Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008 May; 29(2):313-39. View in: PubMed

Building a neuroscience legacy. J Neurosci. 2007 Oct 17; 27(42):11163-6. View in: PubMed

Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J Alzheimers Dis. 2004 Dec; 6(6 Suppl):S27-35. View in: PubMed

Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs. Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs. 2004; 18(7):405-22. View in: PubMed

Neuromodulation: associative and nonlinear adaptation. Brain Res Bull. 1990 May; 24(5):651-8. View in: PubMed

Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther. 1988 Aug; 246(2):803-12. View in: PubMed

Regional distribution of a Ro5 4864 binding site that is functionally coupled to the gamma-aminobutyric acid/benzodiazepine receptor complex in rat brain. J Pharmacol Exp Ther. 1988 Jan; 244(1):379-83. View in: PubMed


Association of Trojan Leagues : Outstanding Service Award for Excellence in Research, Teaching and Service, 2010

The 2010 Presidential Citizens Medal

North American Menopause Society /Wyeth Pharmaceuticals : SERM Research Award, 2009

Society for Neuroscience: Science Educator of the Year, 2006

US News and World Report: 10 Best Minds, 2005

University of Southern California : Remarkable Woman Award, 2003

Laboratory Named “The Kenneth T. and Eileen L. Norris Foundation Laboratory for Neuroscience Researc

University of Southern California: Associates Award for Teaching Excellence, 1996